Related Articles
Prevalence of autoantibodies against Ras‑like GTPases, RalA, in patients with gastric cancer
Possible predictive significance of serum RalA autoantibodies on relapse‑free survival in patients with colorectal cancer
Measurement of serum antibodies against NY‑ESO‑1 by ELISA: A guide for the treatment of specific immunotherapy for patients with advanced colorectal cancer
Expression and immunogenicity of NY‑ESO‑1 in colorectal cancer
NY-ESO-1 expression in hepatocellular carcinoma: A potential new marker for early recurrence after surgery